You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Paricalcitol

Showing 1 - 25 of 125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Pancreatitis Trial in Los Angeles (Paricalcitol, Placebo)

Not yet recruiting
  • Chronic Pancreatitis
  • Paricalcitol
  • Placebo
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 16, 2022

Pancreatic Cancer Trial in Boston, Philadelphia (Gemcitabine, Nab-paclitaxel, Paricalcitol)

Active, not recruiting
  • Pancreatic Cancer
  • Boston, Massachusetts
  • +1 more
Jan 9, 2023

Pancreatic Cancer Trial in Philadelphia (Paricalcitol)

Terminated
  • Pancreatic Cancer
  • Paricalcitol
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 29, 2022

Pancreatic Cancer Trial in Philadelphia (Nivolumab, Nab-Paclitaxel, Gemcitabine)

Terminated
  • Pancreatic Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 19, 2022

Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer Trial in United States (Pembrolizumab, paricalcitol, )

Completed
Has Results
  • Pancreatic Cancer
  • +4 more
  • Scottsdale, Arizona
  • +5 more
Dec 1, 2022

Secondary Hyperparathyroidism Due to Renal Causes, Vitamin D Deficiency, CKD Stage 3 Trial in Garden Grove, Chicago, West Bend

Completed
Has Results
  • Secondary Hyperparathyroidism Due to Renal Causes
  • +3 more
  • Calcifediol Oral Capsule
  • +3 more
  • Garden Grove, California
  • +2 more
Nov 14, 2022

Secondary Hyperparathyroidism Trial (Paricalcitol, Placebo)

Not yet recruiting
  • Secondary Hyperparathyroidism
  • Paricalcitol
  • Placebo
  • (no location specified)
Jan 27, 2022

Efficacy and Safety of Pacitol Inj.

Recruiting
  • Chronic Kidney Disease 5D
  • Secondary Hyperparathyroidism
    • Goyang-si, Gyeonggi-do, Korea, Republic of
      DongGuk university Ilsan hospital
    Nov 6, 2023

    Resectable Pancreatic Carcinoma, Stage I Pancreatic Cancer AJCC v6 and v7, Stage IA Pancreatic Cancer AJCC v6 and v7 Trial in

    Active, not recruiting
    • Resectable Pancreatic Carcinoma
    • +6 more
    • Gemcitabine Hydrochloride
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 16, 2022

    Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta

    Recruiting
    • Advanced Pancreatic Adenocarcinoma
    • +2 more
    • Atlanta, Georgia
    • +2 more
    Feb 28, 2022

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Scottsdale (Paricalcitol (Zemplar))

    Active, not recruiting
    • Pancreatic Cancer
    • +4 more
    • Paricalcitol (Zemplar)
    • Scottsdale, Arizona
      HonorHealth Research Institute
    Feb 16, 2022

    Untreated Metastatic Pancreatic Ductal Adenocarcinoma Trial in Scottsdale (Nivolumab, Albumin-bound paclitaxel, Paricalcitol)

    Active, not recruiting
    • Untreated Metastatic Pancreatic Ductal Adenocarcinoma
    • Scottsdale, Arizona
      HonorHealth Research Institute
    Feb 15, 2022

    Pancreatic Ductal Adenocarcinoma Trial in Philadelphia (Paricalcitol, Hydroxychloroquine, Losartan, Neoadjuvant therapy and

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Paricalcitol, Hydroxychloroquine, Losartan
    • Neoadjuvant therapy and surgery only (Control)
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Jul 7, 2022

    Advanced Pancreatic Cancer Trial in Ireland (Paricalcitol, Gemcitabine (GEM) and Nab-paclitaxel)

    Active, not recruiting
    • Advanced Pancreatic Cancer
    • Paricalcitol
    • Gemcitabine (GEM) and Nab-paclitaxel
    • Dublin, Dublin 24, Ireland
    • +5 more
    Nov 11, 2021

    Resectable Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Scottsdale (Paclitaxel Protein

    Active, not recruiting
    • Resectable Pancreatic Cancer
    • +3 more
    • Paclitaxel Protein Bound (Abraxane)
    • Scottsdale, Arizona
      HonorHealth Research Institute
    Feb 15, 2022

    Pancreatic Cancer, Pancreas Cancer, Cancer of the Pancreas Trial in Saint Louis (5-FU, Leucovorin, Liposomal Irinotecan)

    Active, not recruiting
    • Pancreatic Cancer
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Sep 29, 2021

    Anemia Trial in Palma de Mallorca (Paricalcitol, Epoetin beta, Placebo)

    Recruiting
    • Anemia
    • Paricalcitol
    • +2 more
    • Palma de Mallorca, Islas Baleares, Spain
      Son Espases University Hospital
    Mar 3, 2021

    Moderate to Severe Secondary Hyperparathyroidism, Stage 5 Chronic Kidney Diseases Trial (Paricalcitol, Darbepoetin alfa)

    Completed
    Has Results
    • Moderate to Severe Secondary Hyperparathyroidism
    • Stage 5 Chronic Kidney Diseases
    • Paricalcitol
    • Darbepoetin alfa
    • (no location specified)
    Jul 28, 2021

    Adenocarcinoma of the Pancreas Trial in Philadelphia (Paricalcitol, Abraxane, Gemcitabine)

    Completed
    • Adenocarcinoma of the Pancreas
    • Paricalcitol
    • +2 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Apr 28, 2020

    Vitamin D Receptor Activator Therapy in Stage 3/4 CKD Patients

    Completed
    • CKD Stage 3/4
    • Vitamin D 2mg daily for 2 weeks oral paricalcitol
    • Placebo
    • Chicago, Illinois
      University of Illinois at Chicago
    Aug 13, 2020

    Hypophosphatemia, Familial, Hyperparathyroidism Trial in New Haven (Paricalcitol, Placebo)

    Completed
    Has Results
    • Hypophosphatemia, Familial
    • Hyperparathyroidism
    • Paricalcitol
    • Placebo
    • New Haven, Connecticut
      Yale University School of Medicine
    Mar 3, 2020

    Pancreatic Cancer Trial in London (Paclitaxel protein bound, Cisplatin, Gemcitabine)

    Unknown status
    • Pancreatic Cancer
    • Paclitaxel protein bound
    • +3 more
    • London, London, Greater, United Kingdom
      Barts Health NHS Trust
    Dec 13, 2019

    Chronic Kidney Disease Trial in Ponferrada, León (Paricalcitol, Paricalcitol, atorvastatin, Atorvastatin)

    Completed
    • Chronic Kidney Disease
    • Paricalcitol
    • +2 more
    • Ponferrada, (León)., Spain
    • +1 more
    Aug 22, 2018

    Secondary Hyperparathyroidism Due to Renal Causes Trial in Spain (Paricalcitol, Calcifediol)

    Completed
    Has Results
    • Secondary Hyperparathyroidism Due to Renal Causes
    • Badalona, Barcelona, Spain
    • +15 more
    May 18, 2018

    Hypersensitivity Trial in Amsterdam (Paricalcitol, Placebo (for paricalcitol))

    Completed
    • Hypersensitivity
    • Paricalcitol
    • Placebo (for paricalcitol)
    • Amsterdam, Netherlands
      Academic medical center
    Aug 31, 2018